Shopping Cart
Remove All
Your shopping cart is currently empty
AZ'320 is an ATP-competitive necroptosis inhibitor with an EC50 value of 4.9 μM and a RIPK1 inhibitor with a pKD value of 5.45. It functions by inhibiting RIPK1 phosphorylation, thereby suppressing necroptosis. In systemic inflammatory response syndrome (SIRS) model mice, AZ'320 reduces mortality and restores temperature and weight. This compound can be utilized in cancer and inflammation research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | AZ'320 is an ATP-competitive necroptosis inhibitor with an EC50 value of 4.9 μM and a RIPK1 inhibitor with a pKD value of 5.45. It functions by inhibiting RIPK1 phosphorylation, thereby suppressing necroptosis. In systemic inflammatory response syndrome (SIRS) model mice, AZ'320 reduces mortality and restores temperature and weight. This compound can be utilized in cancer and inflammation research. |
| In vitro | AZ’320 inhibits the phosphorylation level of RIPK1 at the Ser166 site in 12.1 cells in a dose-dependent manner when administered at concentrations of 0.1-10 μM for 4 hours. |
| In vivo | AZ'320 (5 mg/kg, administered intravenously 15 minutes prior to TNF stimulation) reduces mortality in mice models of systemic inflammatory response syndrome (SIRS) and helps restore body temperature and weight, achieving effects comparable to those of Nec-1. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.